Navigation Links
Insomnia: A No-Drug Solution?
Date:12/12/2011

LIEGE, Belgium, December 12, 2011 /PRNewswire/ --

The peer review « BMC Neurology » has published the results of a clinical trial demonstrating the sedative action of the Cefaly® medical device.  

The recent publication, whose abstract is available from the US National Libretry of Medecine (PubMed), reports the results of the HYPNOS I trial.

http://www.ncbi.nlm.nih.gov/pubmed/22035386

The results show, in a statistically highly significant manner using four clinical measurement methods, a pronounced reduction in vigilance induced by the action of the Cefaly® Hypnos medical device, by comparison to a placebo.

This sedative action on the central nervous system is observed after application for 12 minutes in 83% of individuals whose mean increase in tiredness was of 73%.

The Cefaly® is an innovative medical device protected by a series of patents. It is the first external cranial neurostimulation device. It is currently used to treat migraine and headaches and offers the best safety efficacy ratio by comparison to conventional prophylactic drugs.

Numerous patients have reported a tendency to fall asleep when using the Cefaly®. This phenomenon has also been observed during tests or demonstrations. A clinical trial based on strict scientific standards was therefore undertaken to ascertain the veracity of these initial empirical observations. The sedative action demonstrated by the clinical trial is achieved only using certain specific neurostimulation parameters.

The Cefaly Hypnos version is available as a relaxation method for individuals in states of stress or hyperarousal. It should help certain insomniacs achieve sleep more readily. 

http://www.cefaly-insomnie.com/en

http://www.youtube.com/watch?v=I9uTOZTzIZc

http://www.biomedcentral.com/1471-2377/11/135/abstract


'/>"/>
SOURCE STX-Med
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... April 20, 2017  CVS Pharmacy, the retail ... a new store design to enhance the retail ... food, health-focused products and expanded beauty selections paired ... customers discover new offerings. Together with its innovative ... of the customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... The San Juan Capistrano summer camp team at ... outlining the need for summer camps to provide physical activities for all campers. To read ... In Summer Camps , With an increase in specialty camps that focus on what the ...
(Date:4/21/2017)... ... , ... The staff at Palm Beach Face is proud to announce that their practice founder, ... Set to take place on April 23rd, the London Marathon has a long tradition of ... part of team EMPOWER, raising money for the international charity, Smile Train. , ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... and young adults, has kicked off its 4th annual Forum for Innovative Treatment ... theme is “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of ... conviction that the full potential of specialty and orphan brands can only be achieved ... , “The Unifying Effect is at the heart of a true partnership between ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA ... Record (AOR) for Theravent, Inc. , the makers of a revolutionary new ... Consumer Healthcare, is now working to expand distribution in anticipation of a national ...
Breaking Medicine News(10 mins):